Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia

AIM: To assess the efficacy and safety of an intravitreal injection of bevacizumab (Avastin®) for myopic choroidal neovascularisation (mCNV). METHODS: Intravitreal bevacizumab (1 mg) was injected into eight eyes of eight patients with mCNV in this non‐randomised, interventional case series. The best...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sakaguchi, H, Ikuno, Y, Gomi, F, Kamei, M, Sawa, M, Tsujikawa, M, Oshima, Y, Kusaka, S, Tano, Y
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2007
Témata:
Clinical Science - Extended Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1857602/
https://ncbi.nlm.nih.gov/pubmed/16914470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.099887
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky